Imaging procedure can identify biomarker associated with Alzheimer's disease
Tuesday, January 18, 2011 - 17:30
in Health & Medicine
Preliminary research suggests that use of a type of molecular imaging procedure may have the ability to detect the presence of beta-amyloid in the brains of individuals during life, a biomarker that is identified during autopsy to confirm a diagnosis of Alzheimer disease, according to a study in the January 19 issue of JAMA.